Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-danthramer 200mg/25mg/5mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-danthramer strong 1000mg/75mg/5mL oral suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-danthramer strong 500mg/37.5mg capsule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dantron and poloxamer 188 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Co-danthramer strong 500mg/37.5mg capsule (product) |
Has basis of strength substance (attribute) |
False |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Co-danthramer strong 500mg/37.5mg capsule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Co-danthramer strong 500mg/37.5mg capsule (product) |
Has basis of strength substance (attribute) |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dantron- and poloxamer 188-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Co-danthramer strong 500mg/37.5mg capsule (product) |
Has precise active ingredient |
False |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dantron 15 milligram/1 milliliter and poloxamer 188 200 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dantron 15 milligram/1 milliliter and poloxamer 188 200 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension |
Has precise active ingredient |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dantron and poloxamer 188 only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Poloxamer 188-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing poloxamer 188 in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dantron and poloxamer 188 only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only poloxamer 188 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only poloxamer 188 in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Co-danthramer strong 500mg/37.5mg capsule (product) |
Has precise active ingredient |
True |
Poloxamer 188 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |